NanoMedicine International Conference and Exhibition 2018
23 Oct - 25 Oct 2018 | Venice - Italy
Nanomedicine is the science of developing new healthcare breakthroughs that are designed and constructed on the nanometre scale (the nanoscale).
Building components on the nanoscale allows scientists to take advantage of physical, chemical and biological interactions that are not possible on larger size scales. Materials that interact directly with biological structures offer potential for improvements in prevention, detection and treatment of diseases. For example, nanoparticles that are designed to recognise cancer cells can deliver anti-cancer drugs directly to tumor cells while leaving healthy cells intact. This targeted delivery is made possible by engineering materials on the nanoscale to interact directly with the cells of interest.
Nanomedicine covers a wide variety of technologies and applications, but it is usually broken down into two broad areas: diagnostics and therapies. Diagnostics looks at using nanotechnology to aid in the diagnosis of diseases using sensors, analytical assays, or imaging technology. Therapy is usually focussed on drug delivery and interactions in the body that will allow specific targeting of, for example, cancer cells.
Nanomedicine research is generally dependent on collaborative efforts because the science of building nanomedicine ‘devices’ (nanoparticles, nanotubes, functionalised surfaces) is usually heavily dependent on chemistry, chemical engineering and related disciplines, while the application of nanomedicine ‘devices’ to treat disease is heavily dependent on biochemistry, molecular biology, and medically related disciplines. Depending on the application and the device, experience and knowledge from other fields such as physics, electrical engineering, manufacturing engineering and others may be required. As a result, nanomedicine research encompasses nearly all of the science and medical disciplines.